Skeleton density and ellipsoid zone loss are prognostic for progression in Macular Telangiectasia Type 2

Abstract Macular Telangiectasia Type 2 (MacTel) is a chronic, progressive disease of the central retina characterized by vascular and neurodegenerative changes. As there is currently no treatment for non-neovascular MacTel, there is a dearth for biomarkers identifying eyes with an increased risk for...

Full description

Bibliographic Details
Main Authors: Lukas Goerdt, Moritz Berger, Julie Jungblut, Jose Luis Rodriguez Garcia, Kristina Pfau, Philipp Herrmann, Frank G. Holz, Maximilian W. M. Wintergerst
Format: Article
Language:English
Published: Nature Portfolio 2024-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-67801-4